Drugs Approved for Basal Cell Carcinoma：

Aldara (Imiquimod)

Efudex (Fluorouracil--Topical)

Erivedge (Vismodegib)

5-FU (Fluorouracil--Topical)

Fluorouracil--Topical

Imiquimod

Odomzo (Sonidegib)

Sonidegib

Vismodegib

Drugs Approved for Melanoma：

Aldesleukin

Cobimetinib

Cotellic (Cobimetinib)

Dabrafenib

Dacarbazine

DTIC-Dome (Dacarbazine)

IL-2 (Aldesleukin)

Imlygic (Talimogene Laherparepvec)

Interleukin-2 (Aldesleukin)

Intron A (Recombinant Interferon Alfa-2b)

Ipilimumab

Keytruda (Pembrolizumab)

Mekinist (Trametinib)

Nivolumab

Opdivo (Nivolumab)

Peginterferon Alfa-2b

Pembrolizumab

Proleukin (Aldesleukin)

Recombinant Interferon Alfa-2b

Sylatron (Peginterferon Alfa-2b)

Tafinlar (Dabrafenib)

Talimogene Laherparepvec

Trametinib

Vemurafenib

Yervoy (Ipilimumab)

Zelboraf (Vemurafenib)